| 書目名稱 | Management of Prostate Cancer | | 編輯 | Eric A. Klein (Head) | | 視頻video | http://file.papertrans.cn/623/622590/622590.mp4 | | 概述 | Includes supplementary material: | | 叢書名稱 | Current Clinical Urology | | 圖書封面 |  | | 描述 | Although much progress has been made in the four years since the first edition of Management of Prostate Cancer, prostate cancer remains a significant biological, me- cal, and personal challenge for millions of men. In this interval, some important trends and observations have emerged that represent real progress in the field and which will shape the direction of clinical practice and research in the next 5–10 years. These obs- vations include: (1) a decline in prostate-related cancer mortality in the United States, likely owing to a combination of factors including screening, more aggressive and earlier therapy, and improvements in specific therapies; (2) a significant downward pathological stage migration, so that an individual’s chance of cure for a given stage, grade, and PSA is better now than it was early in the PSA era, even without associated improvements in individual therapies; (3) the recognition of new PSA isoforms that may refine screening strategies; (4) several randomized, phase III clinical trials demonstrating survival adv- tages of one form of therapy over another in selected populations (external beam rad- therapy with adjuvant hormones vs radiotherapy alone, rad | | 出版日期 | Book 20042nd edition | | 關鍵詞 | Brachytherapy; Cancer Screening; PSA; Prostate; Prostate Biopsy; Prostatectomy; Radiation therapy; Staging; | | 版次 | 2 | | doi | https://doi.org/10.1007/978-1-59259-776-5 | | isbn_ebook | 978-1-59259-776-5Series ISSN 2197-7194 Series E-ISSN 2197-7208 | | issn_series | 2197-7194 | | copyright | Springer Science+Business Media New York 2004 |
The information of publication is updating
|
|
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網安備110108008328)
GMT+8, 2025-10-15 20:48
發(fā)表于 2025-3-21 19:28:37
